October 4, 2025 at 1:01 AM
🎉 Big congratulations to @karkam.bsky.social who has just been awarded the PRO RETINA Research Award 2025 for her latest paper in American Journal of Human Genetics!
#ResearchAward #AcademicBlueSky #Ophthalmology #MacularDystrophy #Lysosomes #RetinalDisease #VisionResearch #RareDiseases
#ResearchAward #AcademicBlueSky #Ophthalmology #MacularDystrophy #Lysosomes #RetinalDisease #VisionResearch #RareDiseases
New hope for inherited vision loss
IOB researchers (@karkam.bsky.social, @carlorivolta.bsky.social, @mquinodoz.bsky.social, @abimoye.bsky.social) identify AP5Z1, AP5M1, AP5B1 mutations, revealing new causes of macular dystrophy.
🔗 www.cell.com/ajhg/fulltex...
#AcademicBlueSky #Ophthalmology
IOB researchers (@karkam.bsky.social, @carlorivolta.bsky.social, @mquinodoz.bsky.social, @abimoye.bsky.social) identify AP5Z1, AP5M1, AP5B1 mutations, revealing new causes of macular dystrophy.
🔗 www.cell.com/ajhg/fulltex...
#AcademicBlueSky #Ophthalmology
Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP-5 complex cause hereditary macular dystrophy
We discovered genetic changes in three genes (AP5Z1, AP5M1, and AP5B1) that cause
macular degeneration, affecting sharp central vision. The proteins encoded by these
genes form a complex that helps th...
www.cell.com
September 30, 2025 at 11:22 AM
🎉 Big congratulations to @karkam.bsky.social who has just been awarded the PRO RETINA Research Award 2025 for her latest paper in American Journal of Human Genetics!
#ResearchAward #AcademicBlueSky #Ophthalmology #MacularDystrophy #Lysosomes #RetinalDisease #VisionResearch #RareDiseases
#ResearchAward #AcademicBlueSky #Ophthalmology #MacularDystrophy #Lysosomes #RetinalDisease #VisionResearch #RareDiseases
Stem cell therapy for inherited retinal diseases: Trends and insights from 2000 to 2024
doi.org/10.1177/0963...
#eye #retinaldisease #stemcell
@SageJournals
doi.org/10.1177/0963...
#eye #retinaldisease #stemcell
@SageJournals
January 24, 2026 at 12:20 PM
Stem cell therapy for inherited retinal diseases: Trends and insights from 2000 to 2024
doi.org/10.1177/0963...
#eye #retinaldisease #stemcell
@SageJournals
doi.org/10.1177/0963...
#eye #retinaldisease #stemcell
@SageJournals
Do you want to know more about how #killifish research can advance our understanding of retinal diseases? Have a look at Sofia Manzo's exciting work! Sofia is PhD fellow of the MSCA-DN @progret2024.bsky.social
@cabd-upo-csic.bsky.social @jrmarmor.bsky.social
#killifish #retinaldisease #aging
🧬👌🧬
@cabd-upo-csic.bsky.social @jrmarmor.bsky.social
#killifish #retinaldisease #aging
🧬👌🧬
New series launch: discover our PhD projects🚀Curious what ProgRET is all about? Every month, one of our doctoral candidates is explaining their project in a short video.
This is Sofia Manzo's (DC1) month🐟Look at her exciting work at the Andalusian Centre for Developmental Biology in Seville, Spain.
This is Sofia Manzo's (DC1) month🐟Look at her exciting work at the Andalusian Centre for Developmental Biology in Seville, Spain.
February 27, 2026 at 11:15 AM
Do you want to know more about how #killifish research can advance our understanding of retinal diseases? Have a look at Sofia Manzo's exciting work! Sofia is PhD fellow of the MSCA-DN @progret2024.bsky.social
@cabd-upo-csic.bsky.social @jrmarmor.bsky.social
#killifish #retinaldisease #aging
🧬👌🧬
@cabd-upo-csic.bsky.social @jrmarmor.bsky.social
#killifish #retinaldisease #aging
🧬👌🧬
👁️ Recent #AnimalResearch has provided new insights into treating retinal problems & blindness.
👁️ @tuwien.bsky.social found that nerve cells in the retina can carry out different tasks for vision, while Mass Eye and Ear developed a therapy to treat #RetinalDisease.
www.eara.eu/post/mice-an...
Mice and rabbit insights into restoring sight
Recent animal studies in Austria and the US have provided new insights into restoring sight and treating retinal problems and blindness.Researchers at Vienna University of Technology (TU Wien), studyi...
www.eara.eu
December 12, 2024 at 10:21 AM
👁️ Recent #AnimalResearch has provided new insights into treating retinal problems & blindness.
👁️ @tuwien.bsky.social found that nerve cells in the retina can carry out different tasks for vision, while Mass Eye and Ear developed a therapy to treat #RetinalDisease.
www.eara.eu/post/mice-an...
Congratulations to the 2026 @arvoinfo.bsky.social Foundation Early Career Clinician-Scientist Research Awardees — Giovanni Montesano; Richul Oh; Anran Ran and Ganesh Venkataraman. Read about their work using #AI/genetic analysis to combat #glaucoma and #RetinalDisease.
https://bit.ly/4kCl7q4
https://bit.ly/4kCl7q4
February 16, 2026 at 6:45 PM
Congratulations to the 2026 @arvoinfo.bsky.social Foundation Early Career Clinician-Scientist Research Awardees — Giovanni Montesano; Richul Oh; Anran Ran and Ganesh Venkataraman. Read about their work using #AI/genetic analysis to combat #glaucoma and #RetinalDisease.
https://bit.ly/4kCl7q4
https://bit.ly/4kCl7q4
Know an early-career scientist whose discovery profoundly changed treatment of a #retinaldisease. Nominate them for the @arvoinfo.bsky.social Foundation Bert M. Glaser, MD Award for Innovative Research in #Retina. Submit by Oct. 1: https://bit.ly/47YVYS5
September 10, 2025 at 4:12 PM
Know an early-career scientist whose discovery profoundly changed treatment of a #retinaldisease. Nominate them for the @arvoinfo.bsky.social Foundation Bert M. Glaser, MD Award for Innovative Research in #Retina. Submit by Oct. 1: https://bit.ly/47YVYS5
#BeliteBio has said the results of the DRAGON trial of its oral therapy for sight-robbing disorder #Stargardtdisease type 1 (STGD1), tinlarebant, could support an FDA filing. #retinaldisease
pharmaphorum.com/news/belite-...
pharmaphorum.com/news/belite-...
Belite plans filing for oral Stargardt drug after phase 3 win
The first therapy for sight-robbing Stargardt disease could be on the way, as Belite Bio's tinlarebant hits the mark in a phase 3 trial.
pharmaphorum.com
December 1, 2025 at 3:02 PM
#BeliteBio has said the results of the DRAGON trial of its oral therapy for sight-robbing disorder #Stargardtdisease type 1 (STGD1), tinlarebant, could support an FDA filing. #retinaldisease
pharmaphorum.com/news/belite-...
pharmaphorum.com/news/belite-...
Help recognize an early-career investigator making strides in #RetinalDisease research! Nominate them by Oct. 1 for the @arvoinfo.bsky.social Foundation's Bert M. Glaser, MD Award for Innovative #Research in #Retina, which includes $10,000 to further their research. https://bit.ly/4gCehzf
September 15, 2026 at 5:01 PM
Help recognize an early-career investigator making strides in #RetinalDisease research! Nominate them by Oct. 1 for the @arvoinfo.bsky.social Foundation's Bert M. Glaser, MD Award for Innovative #Research in #Retina, which includes $10,000 to further their research. https://bit.ly/4gCehzf
@arvoinfo.bsky.social member Diana Al Abdallat, PharmD (West Virginia University) is making strides exploring the role of glutamine synthetase in maintaining retinal health to uncover potential pathways for future #RetinalDisease therapeutics. https://bit.ly/3Uh4l6T
#SeeWhatMatters #VisionResearch
#SeeWhatMatters #VisionResearch
September 8, 2026 at 4:58 PM
@arvoinfo.bsky.social member Diana Al Abdallat, PharmD (West Virginia University) is making strides exploring the role of glutamine synthetase in maintaining retinal health to uncover potential pathways for future #RetinalDisease therapeutics. https://bit.ly/3Uh4l6T
#SeeWhatMatters #VisionResearch
#SeeWhatMatters #VisionResearch
Can biological age predict #RetinalDisease?
This review explores how #EpigeneticClocks could reveal aging mechanisms, forecast disease progression, and support precision medicine for age-related eye disorders. @usc.edu
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review explores how #EpigeneticClocks could reveal aging mechanisms, forecast disease progression, and support precision medicine for age-related eye disorders. @usc.edu
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
September 5, 2026 at 1:30 PM
Can biological age predict #RetinalDisease?
This review explores how #EpigeneticClocks could reveal aging mechanisms, forecast disease progression, and support precision medicine for age-related eye disorders. @usc.edu
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review explores how #EpigeneticClocks could reveal aging mechanisms, forecast disease progression, and support precision medicine for age-related eye disorders. @usc.edu
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Eyes with high #Myopia may undergo distinct 3-dimensional remodeling patterns that can be linked to ocular outcomes beyond axial elongation, according to research published in JAMA Ophthalmology. @jamaophthalmology.bsky.social
Read more: https://bit.ly/4xWZhDL
#HighMyopia #RetinalDisease
Read more: https://bit.ly/4xWZhDL
#HighMyopia #RetinalDisease
3D Eye Shape Changes in High Myopia Linked to Vision Loss Beyond Axial Growth
A 15-year cohort study identified 3D shape changes in highly myopic eyes that correlate with clinical outcomes beyond axial length.
bit.ly
September 4, 2026 at 6:18 PM
Eyes with high #Myopia may undergo distinct 3-dimensional remodeling patterns that can be linked to ocular outcomes beyond axial elongation, according to research published in JAMA Ophthalmology. @jamaophthalmology.bsky.social
Read more: https://bit.ly/4xWZhDL
#HighMyopia #RetinalDisease
Read more: https://bit.ly/4xWZhDL
#HighMyopia #RetinalDisease
Equip yourself to confidently incorporate anti-VEGF biosimilars into your practice by acquiring a thorough understanding of the regulatory framework, clinical data, pharmacoeconomic advantages, and practical considerations.
👉️ buff.ly/pRgCE8S
#EyeSky #RetinalDisease
👉️ buff.ly/pRgCE8S
#EyeSky #RetinalDisease
Biosimilars of anti-VEGF agents in retinal diseases: a narrative review of regulatory, clinical, and pharmacoeconomic aspects
Equip yourself to confidently incorporate anti-VEGF biosimilars into your practice by acquiring a thorough understanding of the regulatory framework, clinical data, pharmacoeconomic advantages, and…
springermedicine.com
August 30, 2026 at 6:25 PM
Equip yourself to confidently incorporate anti-VEGF biosimilars into your practice by acquiring a thorough understanding of the regulatory framework, clinical data, pharmacoeconomic advantages, and practical considerations.
👉️ buff.ly/pRgCE8S
#EyeSky #RetinalDisease
👉️ buff.ly/pRgCE8S
#EyeSky #RetinalDisease
#MedCase - Autologous retinal grafting may be an effective and safe surgical approach for refractory degenerative macular holes secondary to drug side effects, achieving full anatomic restoration of the fovea.
👉️ buff.ly/LCiBMF9
#EyeSky #RetinalDisease
👉️ buff.ly/LCiBMF9
#EyeSky #RetinalDisease
Bilateral refractory macular holes related to tamoxifen use and full anatomic restoration of the fovea with autologous retinal graft
This case suggests that autologous retinal grafting may be an effective and safe surgical approach for refractory degenerative macular holes secondary to drug side effects, achieving full anatomic…
www.springermedicine.com
July 26, 2026 at 10:54 AM
#MedCase - Autologous retinal grafting may be an effective and safe surgical approach for refractory degenerative macular holes secondary to drug side effects, achieving full anatomic restoration of the fovea.
👉️ buff.ly/LCiBMF9
#EyeSky #RetinalDisease
👉️ buff.ly/LCiBMF9
#EyeSky #RetinalDisease
Patient immune status plays a significant role in determining the clinical characteristics and long-term visual outcomes of #HerpesvirusRetinitis, according to research published in Ophthalmology Retina.
Learn more: https://bit.ly/4yczjfG
#RetinaResearch #RetinalDisease
Learn more: https://bit.ly/4yczjfG
#RetinaResearch #RetinalDisease
Immune Status Influences Herpesvirus Retinitis Phenotypes, Visual Outcomes
Patient immune status is linked to distinct clinical phenotypes and visual outcomes in acute retinal necrosis and cytomegalovirus retinitis.
bit.ly
July 8, 2026 at 9:47 PM
Patient immune status plays a significant role in determining the clinical characteristics and long-term visual outcomes of #HerpesvirusRetinitis, according to research published in Ophthalmology Retina.
Learn more: https://bit.ly/4yczjfG
#RetinaResearch #RetinalDisease
Learn more: https://bit.ly/4yczjfG
#RetinaResearch #RetinalDisease
Spanish biotech #SpliceBio has raised $135 million in #financing that will help it move a #geneediting therapy for an inherited #retinaldisease through clinical testing.
SpliceBio gathers $135m for eye disease gene therapies
Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.
buff.ly
June 11, 2025 at 2:45 PM
Spanish biotech #SpliceBio has raised $135 million in #financing that will help it move a #geneediting therapy for an inherited #retinaldisease through clinical testing.
An 18-year-old patient with #BardetBiedlSyndrome presented with blurry vision and reduced peripheral awareness.
Read the full case report here: https://bit.ly/4xKsdPA
#Optometry #RetinalDisease #GeneticDisorders
Read the full case report here: https://bit.ly/4xKsdPA
#Optometry #RetinalDisease #GeneticDisorders
Optometry Dx: The Retinal Manifestations of Bardet-Biedl Syndrome
How can a patient’s history of Bardet-Biedl syndrome, a rare genetic condition, explain his visual blur and other eye and retina symptoms?
bit.ly
June 15, 2026 at 5:29 PM
An 18-year-old patient with #BardetBiedlSyndrome presented with blurry vision and reduced peripheral awareness.
Read the full case report here: https://bit.ly/4xKsdPA
#Optometry #RetinalDisease #GeneticDisorders
Read the full case report here: https://bit.ly/4xKsdPA
#Optometry #RetinalDisease #GeneticDisorders
Low-dose #Atropine may have limited effect on myopic progression in children with #InheritedRetinalDiseases (IRDs), according to research published in Optometry & Vision Science. @optometryadvisor.bsky.social
Read more: https://bit.ly/4xqwEPs
#MyopiaControl #PediatricOptometry #RetinalDisease
Read more: https://bit.ly/4xqwEPs
#MyopiaControl #PediatricOptometry #RetinalDisease
June 10, 2026 at 7:07 PM
Low-dose #Atropine may have limited effect on myopic progression in children with #InheritedRetinalDiseases (IRDs), according to research published in Optometry & Vision Science. @optometryadvisor.bsky.social
Read more: https://bit.ly/4xqwEPs
#MyopiaControl #PediatricOptometry #RetinalDisease
Read more: https://bit.ly/4xqwEPs
#MyopiaControl #PediatricOptometry #RetinalDisease
Catch up on cutting-edge advances in imaging, diagnostic tools, and therapies in ophthalmology with free access to our coverage of the 2025 #EURETINA congress.
👉 buff.ly/GId9u6w
#EURETINA2025 #RetinalDisease
👉 buff.ly/GId9u6w
#EURETINA2025 #RetinalDisease
December 19, 2025 at 11:54 AM
Catch up on cutting-edge advances in imaging, diagnostic tools, and therapies in ophthalmology with free access to our coverage of the 2025 #EURETINA congress.
👉 buff.ly/GId9u6w
#EURETINA2025 #RetinalDisease
👉 buff.ly/GId9u6w
#EURETINA2025 #RetinalDisease
Delve into this international panel's consensus on ILM peeling extent, vital dye selection, face-down positioning requirements, tamponade options, and more.
👉 buff.ly/H5fafUv
#RetinalDisease #EyeSurgery
👉 buff.ly/H5fafUv
#RetinalDisease #EyeSurgery
December 19, 2025 at 11:54 AM
Delve into this international panel's consensus on ILM peeling extent, vital dye selection, face-down positioning requirements, tamponade options, and more.
👉 buff.ly/H5fafUv
#RetinalDisease #EyeSurgery
👉 buff.ly/H5fafUv
#RetinalDisease #EyeSurgery
Drs. R Chen, HMJ Hussain et al have identified C19orf44 as a novel inherited #retinalDisease-associated #gene jmg.bmj.com/content/jmed... @bcmhouston.bsky.social @bcmgenetics.bsky.social #JMG_BMJ
August 1, 2025 at 5:30 PM
Drs. R Chen, HMJ Hussain et al have identified C19orf44 as a novel inherited #retinalDisease-associated #gene jmg.bmj.com/content/jmed... @bcmhouston.bsky.social @bcmgenetics.bsky.social #JMG_BMJ
Topics include:
🩺 #Hemochromatosis management
📈 #PolygenicRiskScores #PRS in diverse populations
🧬 #CRISPR treating #retinaldisease
👶 #Genome sequencing in #NICUs
…and so much more.
🩺 #Hemochromatosis management
📈 #PolygenicRiskScores #PRS in diverse populations
🧬 #CRISPR treating #retinaldisease
👶 #Genome sequencing in #NICUs
…and so much more.
December 6, 2024 at 8:11 PM
Topics include:
🩺 #Hemochromatosis management
📈 #PolygenicRiskScores #PRS in diverse populations
🧬 #CRISPR treating #retinaldisease
👶 #Genome sequencing in #NICUs
…and so much more.
🩺 #Hemochromatosis management
📈 #PolygenicRiskScores #PRS in diverse populations
🧬 #CRISPR treating #retinaldisease
👶 #Genome sequencing in #NICUs
…and so much more.
Two week warning ⚠️ the poster abstract deadline for our meeting on Macular Degeneration is just under two weeks away ... August 27th at 11:59pm MDT. Make sure to get those abstracts submitted at keysym.us/KSMacularDeg.... #KSMacularDegen25 #maculardegeneration #retinaldisease youtu.be/k-ITXot8dNM
Macular Degeneration Meeting Promo
___ Copyright Keystone Symposia, 2024. All rights reserved. About Keystone Symposia: Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists. Visit Keystone Symposia at: https://www.keystonesymposia.org Visit Virtual Keystone Symposia at: https://virtual.keystonesymposia.org/ For more videos: https://www.youtube.com/user/KeystoneSymposia Follow us on Twitter: https://twitter.com/keystonesymp Like us on Facebook: https://www.facebook.com/KeystoneSymposia Link to us on LinkedIn: https://www.linkedin.com/company/keystone-symposia-on-molecular-and-cellular-biology
youtu.be
August 14, 2024 at 6:35 PM
Two week warning ⚠️ the poster abstract deadline for our meeting on Macular Degeneration is just under two weeks away ... August 27th at 11:59pm MDT. Make sure to get those abstracts submitted at keysym.us/KSMacularDeg.... #KSMacularDegen25 #maculardegeneration #retinaldisease youtu.be/k-ITXot8dNM
リジェネロン、アフリベルセプト8mgのRVO第3相最終64週結果など発表へ──ELARA試験で月1回投与の主要結果も提示予定
Regeneron to Present Final 64-Week Phase 3 QUASAR Results in RVO and Primary Data from Monthly Dosing ELARA Trial of Aflibercept 8 mg
stellanews.life/technology/8...
#RetinalDisease
#Aflibercept
#ClinicalTrials
Regeneron to Present Final 64-Week Phase 3 QUASAR Results in RVO and Primary Data from Monthly Dosing ELARA Trial of Aflibercept 8 mg
stellanews.life/technology/8...
#RetinalDisease
#Aflibercept
#ClinicalTrials
リジェネロン、アフリベルセプト8mgのRVO第3相最終64週結果など発表へ──ELARA試験で月1回投与の主要結果も提示予定 | STELLANEWS.LIFE
STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見
stellanews.life
February 12, 2026 at 2:04 PM
リジェネロン、アフリベルセプト8mgのRVO第3相最終64週結果など発表へ──ELARA試験で月1回投与の主要結果も提示予定
Regeneron to Present Final 64-Week Phase 3 QUASAR Results in RVO and Primary Data from Monthly Dosing ELARA Trial of Aflibercept 8 mg
stellanews.life/technology/8...
#RetinalDisease
#Aflibercept
#ClinicalTrials
Regeneron to Present Final 64-Week Phase 3 QUASAR Results in RVO and Primary Data from Monthly Dosing ELARA Trial of Aflibercept 8 mg
stellanews.life/technology/8...
#RetinalDisease
#Aflibercept
#ClinicalTrials
🧪 Read our interview with first-author, Yujiao Wang. Yujiao is a Lecturer and Ophthalmologist in Danian Chen's lab at West China Hospital, Sichuan University.
#AMD #retinaldisease
https://journals.biologists.com/dmm/article/17/11/dmm052192/363229/First-person-Yujiao-Wang
#AMD #retinaldisease
https://journals.biologists.com/dmm/article/17/11/dmm052192/363229/First-person-Yujiao-Wang
December 19, 2024 at 8:51 AM
🧪 Read our interview with first-author, Yujiao Wang. Yujiao is a Lecturer and Ophthalmologist in Danian Chen's lab at West China Hospital, Sichuan University.
#AMD #retinaldisease
https://journals.biologists.com/dmm/article/17/11/dmm052192/363229/First-person-Yujiao-Wang
#AMD #retinaldisease
https://journals.biologists.com/dmm/article/17/11/dmm052192/363229/First-person-Yujiao-Wang